Regulation of Notch Signaling Pathway to Innate Lymphoid Cells in Patients with Acute Myocardial Infarction

References

• Alam MS, Maekawa Y, Kitamura A, Tanigaki K, Yoshimoto T, Kishihara K, Yasutomo K. 2010. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 107(13):5943–48.
   PubMed Web of Science ®Google Scholar
• Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr., Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, et al. 2013. American college of cardiology foundation/american heart association task force on practice guidelines. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 127(23):e663–828.
   PubMed Web of Science ®Google Scholar
• Aquila G, Pannella M, Morelli MB, Caliceti C, Fortini C, Rizzo P, Ferrari R. 2013. The role of Notch pathway in cardiovascular diseases. Glob Cardiol Sci Pract. 2013(4):364–71.
   PubMedGoogle Scholar
• Artis D, Spits H. 2015. The biology of innate lymphoid cells. Nature. 517(7534):293–301.
   PubMed Web of Science ®Google Scholar
• Castro RC, Goncales RA, Zambuzi FA, Frantz FG. 2021. Notch signaling pathway in infectious diseases: role in the regulation of immune response. Inflamm Res. 70(3):261–74.
   PubMed Web of Science ®Google Scholar
• Chalubinski M, Luczak E, Wojdan K, Gorzelak-Pabis P, Broncel M. 2016. Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis. Immunol Lett. 179:43–46.
   PubMed Web of Science ®Google Scholar
• Chen WY, Wu YH, Tsai TH, Li RF, Lai AC, Li LC, Yang JL, Chang YJ. 2021. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 11(6):2594–611.
   PubMed Web of Science ®Google Scholar
• Deng Y, Wu S, Yang Y, Meng M, Chen X, Chen S, Li L, Gao Y, Cai Y, Imani S, et al. 2020. Unique phenotypes of heart resident type 2 innate lymphoid cells. Front Immunol. 11:802.
   PubMed Web of Science ®Google Scholar
• Engelbertsen D, Foks AC, Alberts-Grill N, Kuperwaser F, Chen T, Lederer JA, Jarolim P, Grabie N, Lichtman AH. 2015. Expansion of CD25+ innate lymphoid cells reduces atherosclerosis. Arterioscler Thromb Vasc Biol. 35(12):2526–35.
   PubMed Web of Science ®Google Scholar
• Engelbertsen D, Lichtman AH. 2017. Innate lymphoid cells in atherosclerosis. Eur J Pharmacol. 816:32–36.
   PubMed Web of Science ®Google Scholar
• Fazio C, Ricciardiello L. 2016. Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesis. Cell Death Dis. 7(12):e2515.
   PubMedGoogle Scholar
• Gang H, Peng D, Hu Y, Tang S, Li S, Huang Q. 2021. Interleukin-9-secreting CD4(+) T cells regulate CD8(+) T cells cytotoxicity in patients with acute coronary syndromes. APMIS. 129(2):91–102.
   PubMed Web of Science ®Google Scholar
• Gao X, Lin J, Zheng Y, Liu S, Liu C, Liu T, Wang B, He S, Li D. 2020. Type 2 innate lymphoid cells regulation by regulatory T cells attenuates atherosclerosis. J Mol Cell Cardiol. 145:99–111.
   PubMed Web of Science ®Google Scholar
• Geremia A, Arancibia-Carcamo CV. 2017. Innate lymphoid cells in intestinal inflammation. Front Immunol. 8:1296.
   PubMed Web of Science ®Google Scholar
• Jiang BC, Liu X, Liu XH, Li ZS, Zhu GZ. 2017. Notch signaling regulates circulating T helper 22 cells in patients with chronic hepatitis C. Viral Immunol. 30(7):522–32.
   PubMed Web of Science ®Google Scholar
• Jonusiene V, Sasnauskiene A, Lachej N, Kanopiene D, Dabkeviciene D, Sasnauskiene S, Kazbariene B, Didziapetriene J. 2013. Down-regulated expression of Notch signaling molecules in human endometrial cancer. Med Oncol. 30(1):438.
   PubMed Web of Science ®Google Scholar
• Keewan E, Naser SA. 2020. The role of Notch signaling in macrophages during Inflammation and Infection: implication in rheumatoid arthritis? Cells. 9(1):cells9010111.
   Web of Science ®Google Scholar
• Lim AI, Di Santo JP. 2019. ILC-poiesis: ensuring tissue ILC differentiation at the right place and time. Eur J Immunol. 49(1):11–18.
   PubMed Web of Science ®Google Scholar
• Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, et al. 2017. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell. 168(6):1086–100 e1010.
   PubMed Web of Science ®Google Scholar
• Lin QQ, Zhao J, Zheng CG, Chun J. 2018. Roles of notch signaling pathway and endothelial-mesenchymal transition in vascular endothelial dysfunction and atherosclerosis. Eur Rev Med Pharmacol Sci. 22(19):6485–91.
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Tan Y, Beecham GW, Seo DM, Tian R, Li Y, Vazquez-Padron RI, Pericak-Vance M, Vance JM, Goldschmidt-Clermont PJ, et al. 2012. Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis. Atherosclerosis. 225(2):296–303.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang H, Wang X, Xie G. 2019. MiR-29b inhibits ventricular remodeling by activating Notch signaling pathway in the rat myocardial infarction model. Heart Surg Forum. 22(1):E019–023.
   PubMed Web of Science ®Google Scholar
• Liubomirski Y, Ben-Baruch A. 2020. Notch-inflammation networks in regulation of breast cancer progression. Cells. 9(7):cells9071576.
   Web of Science ®Google Scholar
• Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ. 2007. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci U S A. 104(9):3219–24.
   PubMed Web of Science ®Google Scholar
• Lopez-Yglesias AH, Burger E, Camanzo E, Martin AT, Araujo AM, Kwok SF, Yarovinsky F. 2021. T-bet-dependent ILC1- and NK cell-derived IFN-γ mediates cDC1-dependent host resistance against toxoplasma gondii. PLoS Pathog. 17(1):e1008299.
   PubMed Web of Science ®Google Scholar
• Makki N, Brennan TM, Girotra S. 2015. Acute coronary syndrome. J Intensive Care Med. 30(4):186–200.
   PubMed Web of Science ®Google Scholar
• Matsuda T, Miyagawa S, Fukushima S, Kitagawa-Sakakida S, Akimaru H, Horii-Komatsu M, Kawamoto A, Saito A, Asahara T, Sawa Y. 2014. Human cardiac stem cells with reduced notch signaling show enhanced therapeutic potential in a rat acute infarction model. Circ J. 78(1):222–31.
   PubMed Web of Science ®Google Scholar
• Mazzurana L, Forkel M, Rao A, Van Acker A, Kokkinou E, Ichiya T, Almer S, Hoog C, Friberg D, Mjosberg J. 2019. Suppression of aiolos and ikaros expression by lenalidomide reduces human ILC3−ILC1/NK cell transdifferentiation. Eur J Immunol. 49(9):1344–55.
   PubMed Web of Science ®Google Scholar
• Mjosberg J, Mazzurana L. 2017. ILC-poiesis: making tissue ILCs from blood. Immunity. 46(3):344–46.
   PubMed Web of Science ®Google Scholar
• Perchet T, Petit M, Banchi EG, Meunier S, Cumano A, Golub R. 2018. The Notch signaling pathway is balancing type 1 innate lymphoid cell immune functions. Front Immunol. 9:1252.
   PubMed Web of Science ®Google Scholar
• Qin L, Zhou YC, Wu HJ, Zhuo Y, Wang YP, Si CY, Qin YM. 2017. Notch signaling modulates the balance of regulatory T cells and T helper 17 cells in patients with chronic hepatitis C. DNA Cell Biol. 36(4):311–20.
   PubMed Web of Science ®Google Scholar
• Qiu XX, Chen L, Wang CH, Lin ZX, Chen BJ, You N, Chen Y, Wang XF. 2016. The vascular Notch ligands delta-like ligand 4 (DLL4) and jagged1 (JAG1) have opposing correlations with microvascularization but a uniform prognostic effect in primary glioblastoma: a preliminary study. World Neurosurg. 88:447–58.
   PubMed Web of Science ®Google Scholar
• Radtke F, Fasnacht N, Macdonald HR. 2010. Notch signaling in the immune system. Immunity. 32(1):14–27.
   PubMed Web of Science ®Google Scholar
• Rani A, Greenlaw R, Smith RA, Galustian C. 2016. HES1 in immunity and cancer. Cytokine Growth Factor Rev. 30:113–17.
   PubMed Web of Science ®Google Scholar
• Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. 2015. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 28(2):283–93.
   PubMed Web of Science ®Google Scholar
• Spits H, Di Santo JP. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 12(1):21–27.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Mendis S, Vasilieva EJ, Parkhomenko AN, Bove AA, Tendera M, Weaver D, et al. 2012. Third universal definition of myocardial infarction. Circulation. 126(16):2020–35.
   PubMed Web of Science ®Google Scholar
• Vieceli Dalla Sega F, Fortini F, Aquila G, Campo G, Vaccarezza M, Rizzo P. 2019. Notch signaling regulates immune responses in atherosclerosis. Front Immunol. 10:1130.
   PubMed Web of Science ®Google Scholar
• Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, et al. 2018. Innate lymphoid cells: 10 years on. Cell. 174(5):1054–66.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Xing X, Xue H, Qi R, Ji H, Ma L. 2020. Notch-hes1 signaling regulates IL-17A(+) gammadelta (+)T cell expression and IL-17A secretion of mouse psoriasis-like skin inflammation. Mediators Inflamm. 2020:8297134.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu Z, Shao J, Lin L, Jiang M, Wang L, Lu X, Zhang H, Chen Y, Zhang R. 2020. Immune and inflammation in acute coronary syndrome: molecular mechanisms and therapeutic implications. J Immunol Res. 2020:4904217.
   PubMed Web of Science ®Google Scholar
• Wei X, Wang JP, Hao CQ, Yang XF, Wang LX, Huang CX, Bai XF, Lian JQ, Zhang Y. 2016. Notch signaling contributes to liver inflammation by regulation of interleukin-22-producing cells in hepatitis B virus infection. Front Cell Infect Microbiol. 6:132.
   PubMed Web of Science ®Google Scholar
• Wu C, He S, Liu J, Wang B, Lin J, Duan Y, Gao X, Li D. 2018. Type 1 innate lymphoid cell aggravation of atherosclerosis is mediated through TLR4. Scand J Immunol. 87(5):e12661.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Chen G, Pang NN, Guo XH, Wang L, Zhao F, Tan MF, Qu JH. 2015. mRNA Expressions of T-bet, GATA-3, ROR γt and Foxp3 in peripheral blood of patients with chronic lymphocytic leukemia in different stages. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 23(1):45–49.
   PubMedGoogle Scholar
• Yuan JS, Kousis PC, Suliman S, Visan I, Guidos CJ. 2010. Functions of notch signaling in the immune system: consensus and controversies. Annu Rev Immunol. 28(1):343–65.
   PubMedGoogle Scholar
• Zhang J, Marotel M, Fauteux-Daniel S, Mathieu AL, Viel S, Marcais A, Walzer T. 2018. T-bet and eomes govern differentiation and function of mouse and human NK cells and ILC1. Eur J Immunol. 48(5):738–50.
   PubMed Web of Science ®Google Scholar
• Zhang K, Xu X, Pasha MA, Siebel CW, Costello A, Haczku A, MacNamara K, Liang T, Zhu J, Bhandoola A, et al. 2017. Cutting edge: Notch signaling promotes the plasticity of group-2 innate lymphoid cells. J Immunol. 198(5):1798–803.
   PubMed Web of Science ®Google Scholar